文献速递基础与转化研究新药、器械与细胞基因治疗研发组学、生物样本库与精准医学

Christianson综合征iPSC来源人神经元揭示突变特异性挽救策略反应

Human neurons from Christianson syndrome iPSCs reveal mutation-specific responses to rescue strategies.
PubMed 文献 · Sci Transl Med · 2021-01-01

研究利用Christianson综合征(CS)患者iPSC来源神经元,涵盖多种SLC9A6突变及对照系,发现致病突变通过不同机制导致蛋白功能丧失,患者神经元均表现为神经突生长和分支减少;基因转移对无义突变有效但对G383D突变无效,而外源性BDNF或IGF-1可挽救所有突变的表型。

要点

  • CS患者iPSC神经元普遍存在神经突生长和分支减少,可能解释出生后脑生长衰减。
  • 多数SLC9A6突变因无义介导mRNA衰减导致mRNA缺失,G383D错义突变兼具功能丧失和显性负性活性。
  • 基因转移对无义突变有效但对G383D无效,外源性BDNF或IGF-1可挽救所有突变的神经突分支表型。

核心结论

  • CS患者iPSC来源神经元显示突变特异性治疗反应,基因治疗应答可能由突变类型决定。

研究设计与样本

  • 建立CS患者iPSC系,涵盖突变谱及生物学相关和同基因对照系,诱导分化为神经元进行研究。

主要发现

  • 多数致病突变因无义介导mRNA衰减导致mRNA缺失,G383D错义突变兼具功能丧失和显性负性活性。
  • 所有患者来源神经元均显示神经突生长和分支减少。
  • 基因转移对无义突变有效,但对G383D突变无效,残余蛋白似乎干扰挽救。
  • 外源性BDNF或IGF-1可挽救所有突变的神经突分支表型。

临床怎么用

  • CS治疗开发需考虑突变类型,基因治疗策略可能对无义突变有效而对G383D突变无效。
  • 外源性营养因子BDNF或IGF-1可能作为跨突变类型的表型挽救策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Christianson syndrome (CS), an X-linked neurological disorder characterized by postnatal attenuation of brain growth (postnatal microcephaly), is caused by mutations in SLC9A6, the gene encoding endosomal Na+/H+ exchanger 6 (NHE6). To hasten treatment development, we established induced pluripotent stem cell (iPSC) lines from patients with CS representing a mutational spectrum, as well as biologically related and isogenic control lines. We demonstrated that pathogenic mutations lead to loss of protein function by a variety of mechanisms: The majority of mutations caused loss of mRNA due to nonsense-mediated mRNA decay; however, a recurrent, missense mutation (the G383D mutation) had both loss-of-function and dominant-negative activities. Regardless of mutation, all patient-derived neurons demonstrated reduced neurite growth and arborization, likely underlying diminished postnatal brain growth in patients. Phenotype rescue strategies showed mutation-specific responses: A gene transfer strategy was effective in nonsense mutations, but not in the G383D mutation, wherein residual protein appeared to interfere with rescue. In contrast, application of exogenous trophic factors (BDNF or IGF-1) rescued arborization phenotypes across all mutations. These results may guide treatment development in CS, including gene therapy strategies wherein our data suggest that response to treatment may be dictated by the class of mutation.

来源:Sci Transl Med,查看原文。版权归原作者所有。

引用

  1. Lizarraga SB, Ma L, Maguire AM, et al. Human neurons from Christianson syndrome iPSCs reveal mutation-specific responses to rescue strategies. Sci Transl Med. 2021. PMID: 33568516. doi:10.1126/scitranslmed.aaw0682

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。